189 related articles for article (PubMed ID: 37558663)
1. PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.
Jia Y; Yu X; Liu R; Shi L; Jin H; Yang D; Zhang X; Shen Y; Feng Y; Zhang P; Yang Y; Zhang L; Zhang P; Li Z; He A; Kong G
Cell Death Dis; 2023 Aug; 14(8):512. PubMed ID: 37558663
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 methylates METTL14 to modulate its oncogenic function.
Wang J; Wang Z; Inuzuka H; Wei W; Liu J
Neoplasia; 2023 Aug; 42():100912. PubMed ID: 37269817
[TBL] [Abstract][Full Text] [Related]
3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
4. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X
Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202
[TBL] [Abstract][Full Text] [Related]
5. Protection of c-Fos from autophagic degradation by PRMT1-mediated methylation fosters gastric tumorigenesis.
Kim E; Rahmawati L; Aziz N; Kim HG; Kim JH; Kim KH; Yoo BC; Parameswaran N; Kang JS; Hur H; Manavalan B; Lee J; Cho JY
Int J Biol Sci; 2023; 19(12):3640-3660. PubMed ID: 37564212
[TBL] [Abstract][Full Text] [Related]
6. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
7. Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion.
Liu Y; Liu H; Ye M; Jiang M; Chen X; Song G; Ji H; Wang ZW; Zhu X
Cell Death Dis; 2023 Sep; 14(9):624. PubMed ID: 37737256
[TBL] [Abstract][Full Text] [Related]
8. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis.
Li WJ; Huang Y; Lin YA; Zhang BD; Li MY; Zou YQ; Hu GS; He YH; Yang JJ; Xie BL; Huang HH; Deng X; Liu W
Cell Rep; 2023 Nov; 42(11):113385. PubMed ID: 37938975
[TBL] [Abstract][Full Text] [Related]
9. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
11. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
[TBL] [Abstract][Full Text] [Related]
12. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma.
Nguyen HP; Le AQ; Liu E; Cesarano A; DiMeo F; Perna F; Kapur R; Walker BA; Tran NT
Front Immunol; 2023; 14():1239614. PubMed ID: 37600810
[TBL] [Abstract][Full Text] [Related]
14. TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.
Yang M; Zhang Y; Liu G; Zhao Z; Li J; Yang L; Liu K; Hu W; Lou Y; Jiang J; Liu Q; Zhao P
Cell Death Dis; 2022 Sep; 13(9):815. PubMed ID: 36151091
[TBL] [Abstract][Full Text] [Related]
15. The role of protein arginine-methyltransferase 1 in gliomagenesis.
Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
Herrmann F; Lee J; Bedford MT; Fackelmayer FO
J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
[TBL] [Abstract][Full Text] [Related]
17. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 in human neoplasm: cancer biology and potential therapeutic target.
Shen S; Zhou H; Xiao Z; Zhan S; Tuo Y; Chen D; Pang X; Wang Y; Wang J
Cell Commun Signal; 2024 Feb; 22(1):102. PubMed ID: 38326807
[TBL] [Abstract][Full Text] [Related]
19. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
20. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
Nakai K; Xia W; Liao HW; Saito M; Hung MC; Yamaguchi H
Breast Cancer; 2018 Jan; 25(1):74-80. PubMed ID: 28643125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
